Skip to main content

Table 1 Patient characteristics

From: A retrospective study of prostate cancer cases mimicking urothelial cell carcinoma of the bladder

Number Age (years) Clinical symptoms PSA (ng/ml) DRE Cytology2 Gleason score Clinical staging Treatment Follow-up duration (months)/outcome
1 54 dysuria, frequent micturition (1 month) 11.5 III° enlargement, hard palpable lumps (right) + 8 T4N1M1b TURP surgical castration 22/death
2 72 frequent/urgent micturition (3 months) 19.9 II° enlargement, hard, no palpable lump + 7 T4N1M1b surgical castration 56/death
3 75 dysuria, frequent micturition (2 years) hematuria (1 month) 55.0 III° enlargement, soft, palpable lump (right) - 8 T4N1M1b TURP surgical castration 39/death
4 74 intermittent painless gross hematuria (6 years) 150.0 II° enlargement, hard, palpable lump (left) - 7 T4N0M0 endocrine therapy chemotherapy 50/survival
51 68 dysuria, frequent/urgent micturition (2 months) 31.7 III° enlargement, soft, no palpable lump - - T4N0M0 TURP surgical castration 23/death
6 70 dysuria, frequent micturition (3 years) hematuria (1 week) 38.9 II° enlargement, hard, palpable lump (right) + 7 T4N1M1b surgical castration 40/death
7 58 dysuria, frequent micturition (1 month) 40.5 III° enlargement, hard, no palpable lump - 7 T4N0M0 TURP surgical castration 30/survival
8 77 frequent/urgent micturition, (1 year) 30.5 III° enlargement, soft, no touchable lump - 8 T4N1M1b TURP surgical castration loss to follow-up
9 69 dysuria frequent/painful micturition (1 year) 29.9 II° enlargement, hard, no palpable lump - 7 T4N1M1b surgical castration anti-androgen drug 47/survival
10 78 frequent/urgent micturition (1 year) 75.0 II° enlargement, soft, no touchable lump - 7 T4N0M0 surgical castration loss to follow-up
111 80 dysuria, frequent urination (3 years), hematuria (4 days) 13.5 III° enlargement soft no palpable lump - - T4N0M0 TURP endocrine therapy 21/survival
12 71 dysuria, frequent/urgent micturition (6 months) 27.0 III° enlargement, hard, palpable lump (right) + 8 T4N0M0 TURP surgical castration loss to follow-up
13 76 intermittent, painless, gross hematuria (1 month) 110.3 IV° enlargement, hard, no palpable lump + 8 T4N0M0 TURP endocrine therapy 16/survival
14 66 dysuria, frequent/urgent micturition (6 months) 160.0 IV° enlargement, hard, no palpable lump - 9 T4N0M0 TURP endocrine therapy 12/survival
  1. DRE, digital rectal examination; PSA, prostate-specific antigen; TURP, transurethral resection of the prostate.
  2. 1patients diagnosed with HGPIN;
  3. 2exfoliative urine cytology analysis using acridine orange fluorescence staining has been done three times with the consistent results as shown as follows.
  4. “°” means the degree of the enlargement of prostate.